Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid E Lundberg

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Current Opinion in Rheumatology|November 1, 2002
New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathiesIngrid E Lundberg
Current Opinion in Rheumatology|October 22, 2003
Clinical symptoms in patients with myositis-an acquired metabolic myopathy?Ingrid E Lundberg
The New England Journal of Medicine|May 13, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisIngrid E Lundberg
Nature Reviews. Rheumatology|January 26, 2017
Myositis in 2016: New tools for diagnosis and therapyIngrid E Lundberg
Arthritis & Rheumatology (Hoboken, N.J.)|April 12, 2021
Expert Perspective: Management of Refractory Inflammatory MyopathyIngrid E Lundberg
Rheumatic Diseases Clinics of North America|August 9, 2005
The prognosis of mixed connective tissue diseaseIngrid E Lundberg
Nature Reviews. Rheumatology|April 7, 2011
Pathogenesis, classification and treatment of inflammatory myopathiesMei Zong, Ingrid E Lundberg
Rheumatic Diseases Clinics of North America|March 30, 2011
Polymyositis and dermatomyositis: pathophysiologyKanneboyina Nagaraju, Ingrid E Lundberg
Annals of the Rheumatic Diseases|May 10, 2019
Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>' by Knitza <i>et al</i>Anna Tjärnlund, Ingrid E Lundberg
Autoimmunity|June 14, 2006
Cytokines in idiopathic inflammatory myopathiesStina Salomonsson, Ingrid E Lundberg
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Current Opinion in Rheumatology|November 1, 2002
New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathiesIngrid E Lundberg
Current Opinion in Rheumatology|October 22, 2003
Clinical symptoms in patients with myositis-an acquired metabolic myopathy?Ingrid E Lundberg
The New England Journal of Medicine|May 13, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisIngrid E Lundberg
Nature Reviews. Rheumatology|January 26, 2017
Myositis in 2016: New tools for diagnosis and therapyIngrid E Lundberg
Arthritis & Rheumatology (Hoboken, N.J.)|April 12, 2021
Expert Perspective: Management of Refractory Inflammatory MyopathyIngrid E Lundberg
Rheumatic Diseases Clinics of North America|August 9, 2005
The prognosis of mixed connective tissue diseaseIngrid E Lundberg
Nature Reviews. Rheumatology|April 7, 2011
Pathogenesis, classification and treatment of inflammatory myopathiesMei Zong, Ingrid E Lundberg
Rheumatic Diseases Clinics of North America|March 30, 2011
Polymyositis and dermatomyositis: pathophysiologyKanneboyina Nagaraju, Ingrid E Lundberg
Annals of the Rheumatic Diseases|May 10, 2019
Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco <i>et al</i>' by Knitza <i>et al</i>Anna Tjärnlund, Ingrid E Lundberg
Autoimmunity|June 14, 2006
Cytokines in idiopathic inflammatory myopathiesStina Salomonsson, Ingrid E Lundberg
Pageof 30